QT
AKCA

Quantamental Technologies’s Akcea Therapeutics Inc AKCA Stock Holding History

Quantamental Technologies’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11
Closed – – 1954
2019
Q2 		$0 Sell
11
-2,600
-100% -$64.2K ﹤0.01% 1938
2019
Q1 		$74K Buy
+2,611
New +$76K 0.03% 715

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Quantamental Technologies's AKCA Position: Q3 2019 in Review

Quantamental Technologies sold out of Akcea Therapeutics Inc (AKCA) in Q3 2019, closing a stake of 11 shares.

Quantamental Technologies first reported a position in AKCA in Q1 2019 and held it in 2 quarters. The position peaked at $74K in Q1 2019. 62 funds tracked by Wall St. Rank hold AKCA as of Q3 2019.

  • Quantamental Technologies reported no remaining Akcea Therapeutics Inc position as of Q3 2019 after selling out during the quarter.
  • Quantamental Technologies sold 11 Akcea Therapeutics Inc shares in Q3 2019.
  • Quantamental Technologies first reported a position in Akcea Therapeutics Inc in Q1 2019 and held it in 2 quarters.
  • Quantamental Technologies's Akcea Therapeutics Inc position peaked at $74K in Q1 2019.
  • 62 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q3 2019.

Based on Quantamental Technologies's 13F filing for Q3 2019, filed 8 Nov 2019.